Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • pharma

    Tag: pharma

    You Searched For "pharma"
    Suven Life Sciences secures Product Patent in Brazil, Eurasia

    Suven Life Sciences secures Product Patent in Brazil, Eurasia

    Garima29 March 2019 9:40 AM IST
    The granted claims of patents are being developed as therapeutic agents useful in treatment of cognitive impairment associated with neurodegenerative...
    AstraZeneca, Daiichi Sankyo sign $6.9 billion cancer drug deal

    AstraZeneca, Daiichi Sankyo sign $6.9 billion cancer drug deal

    Garima29 March 2019 9:15 AM IST
    Under the deal, AstraZeneca will pay Daiichi up to $6.9 billion, including a $1.35 billion upfront payment. The two companies will share development...
    Dr Reddy

    Dr Reddy's launches Tadalafil Tablets to treat erectile dysfunction

    Farhat Nasim28 March 2019 12:06 PM IST
    Dr Reddy's Tadalafil tablets are available in four strengths including 2.5 mg, 5 mg, 10 mg, and 20 mg, each in 30-count bottle size.New Delhi: Dr...
    AstraZeneca gets EU nod to diabetes drug Forxiga

    AstraZeneca gets EU nod to diabetes drug Forxiga

    Medical Dialogues Bureau27 March 2019 2:55 PM IST
    Farxiga or Forxiga, as the drug is known outside the United States, is one of AstraZeneca's top ten drugs by sales. It generated $1.39 billion in 2018...
    JnJ, Bayer settles Xarelto lawsuits for 775 million Dollar

    JnJ, Bayer settles Xarelto lawsuits for 775 million Dollar

    Farhat Nasim27 March 2019 12:24 PM IST
    Lawsuits over Xarelto began piling up in 2014 and the companies had so far won all six trials over Xarelto's alleged bleeding risk.U.S: Bayer AG and...
    Alkem Labs gets 8 USFDA observations for St Louis facility

    Alkem Labs gets 8 USFDA observations for St Louis facility

    Farhat Nasim24 March 2019 9:50 AM IST
    The United States Food and Drug Administration (USFDA) had issued eight observations after inspecting the company's manufacturing plant at St Louis...
    Lupin launches generic Levothyroxine Sodium tablets

    Lupin launches generic Levothyroxine Sodium tablets

    Farhat Nasim22 March 2019 11:30 AM IST
    Lupin's Levothyroxine Sodium tablet is the generic version of AbbVie Inc's Synthroid tablets, it added. New Delhi: Drug firm Lupin Friday said it has...
    USFDA puts partial hold on Abbvie Venclexta clinical trials after deaths

    USFDA puts partial hold on Abbvie Venclexta clinical trials after deaths

    Farhat Nasim21 March 2019 9:45 AM IST
    The clinical hold does not impact any of the approved indications for Venclexta, such as chronic lymphocytic leukaemia (CLL) or acute myeloid...
    Novartis division Alcon acquires Power Vision

    Novartis division Alcon acquires Power Vision

    Garima20 March 2019 9:47 AM IST
    Under the terms of the agreement, Alcon, a Novartis division paid USD 285 million to PowerVision at closing with additional payments based on...
    Merck, Enigma Biomedical signs license agreement for Novel MK 6884 Imaging Agent

    Merck, Enigma Biomedical signs license agreement for Novel MK 6884 Imaging Agent

    Garima20 March 2019 9:46 AM IST
    As part of the agreement with Merck, EBG will be responsible for the clinical development and commercialization of MK-6884 in return for payment of...
    Lupin launches Minocycline Hydrochloride extended release tablets in US

    Lupin launches Minocycline Hydrochloride extended release tablets in US

    Farhat Nasim27 Feb 2019 9:40 AM IST
    The company has launched Minocycline Hydrochloride extended-release tablets USP in the strength of 55 mg, after receiving approval from the United...
    Setback to Sanofi: Court refuses to quash corruption case, directs CBI to continue inquiry

    Setback to Sanofi: Court refuses to quash corruption case, directs CBI to continue inquiry

    Meghna A Singhania18 Feb 2019 6:03 PM IST
    It was alleged that BARC employees reportedly influenced the selection of tenders for the purchase of drugs. They illegally favoured Sanofi and...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok